Ultromics is highlighting clinical results for its EchoGo Heart Failure software that were published July 28 in JACC Advances.
EchoGo was trained and developed on data from 6,756 patients who underwent a comprehensive transthoracic echocardiographic exam at Mayo Clinic in Rochester, MN, between January 2009 to December 2020.
The JACC Advances study showed that applying EchoGo to a single apical four chamber (A4C) view echocardiogram produced accurate information to detect heart failure with preserved ejection fraction (HFpEF) and that it demonstrated high sensitivity and specificity, detecting 87.8% of patients who had HFpEF, and 81.9% of patients who did not, Ultromics said.
The complete study can be found here.
